Guangxi Hongxiang Yixintang Pharmaceutical Co., Ltd. announced that it will receive CNY 150,000,000 in its equity round of funding from existing investor, Yunnan Hongxiang Yixintang Pharmaceutical Co., Ltd. (SZSE:002727) on October 25, 2016. The investor will continue to hold 100% stake in the company. The registered capital of the company will increase from CNY 109,000,000 to CNY 259,000,000 upon closing. The transaction has been approved at 28th session of the 3rd directorate of the investor. The company reported total assets of CNY 265,824,967.36, liabilities of CNY 226,381,228.88, net assets of CNY 39,443,738.48, operating revenues of CNY 329,770,389.93, and net loss of CNY 1,513,512.84 for the year ended December 31, 2015.